Skip to main content
The BMJ logoLink to The BMJ
. 1988 Sep 3;297(6648):573–574. doi: 10.1136/bmj.297.6648.573

Selenium and cancer.

W C Willett 1, M J Stampfer 1
PMCID: PMC1834550  PMID: 3139218

Full text

PDF
573

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cech I., Holguin A., Sokolow H., Smith V. Selenium availability in Texas: possible clinical significance. South Med J. 1984 Nov;77(11):1415–1420. doi: 10.1097/00007611-198411000-00016. [DOI] [PubMed] [Google Scholar]
  2. Clark L. C., Graham G. F., Crounse R. G., Grimson R., Hulka B., Shy C. M. Plasma selenium and skin neoplasms: a case-control study. Nutr Cancer. 1984;6(1):13–21. [PubMed] [Google Scholar]
  3. Fex G., Pettersson B., Akesson B. Low plasma selenium as a risk factor for cancer death in middle-aged men. Nutr Cancer. 1987;10(4):221–229. doi: 10.1080/01635588709513960. [DOI] [PubMed] [Google Scholar]
  4. Kok F. J., de Bruijn A. M., Hofman A., Vermeeren R., Valkenburg H. A. Is serum selenium a risk factor for cancer in men only? Am J Epidemiol. 1987 Jan;125(1):12–16. doi: 10.1093/oxfordjournals.aje.a114493. [DOI] [PubMed] [Google Scholar]
  5. McConnell K. P., Broghamer W. L., Jr, Blotcky A. J., Hurt O. J. Selenium levels in human blood and tissues in health and in disease. J Nutr. 1975 Aug;105(8):1026–1031. doi: 10.1093/jn/105.8.1026. [DOI] [PubMed] [Google Scholar]
  6. Menkes M. S., Comstock G. W., Vuilleumier J. P., Helsing K. J., Rider A. A., Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med. 1986 Nov 13;315(20):1250–1254. doi: 10.1056/NEJM198611133152003. [DOI] [PubMed] [Google Scholar]
  7. Peleg I., Morris S., Hames C. G. Is serum selenium a risk factor for cancer? Med Oncol Tumor Pharmacother. 1985;2(3):157–163. doi: 10.1007/BF02934543. [DOI] [PubMed] [Google Scholar]
  8. Rizk S. L., Sky-Peck H. H. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. Cancer Res. 1984 Nov;44(11):5390–5394. [PubMed] [Google Scholar]
  9. Robinson M. F., Godfrey P. J., Thomson C. D., Rea H. M., van Rij A. M. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am J Clin Nutr. 1979 Jul;32(7):1477–1485. doi: 10.1093/ajcn/32.7.1477. [DOI] [PubMed] [Google Scholar]
  10. Rotruck J. T., Pope A. L., Ganther H. E., Swanson A. B., Hafeman D. G., Hoekstra W. G. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973 Feb 9;179(4073):588–590. doi: 10.1126/science.179.4073.588. [DOI] [PubMed] [Google Scholar]
  11. Salonen J. T., Alfthan G., Huttunen J. K., Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol. 1984 Sep;120(3):342–349. doi: 10.1093/oxfordjournals.aje.a113898. [DOI] [PubMed] [Google Scholar]
  12. Salonen J. T., Salonen R., Lappeteläinen R., Mäenpä P. H., Alfthan G., Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J (Clin Res Ed) 1985 Feb 9;290(6466):417–420. doi: 10.1136/bmj.290.6466.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schrauzer G. N., White D. A., Schneider C. J. Cancer mortality correlation studies--III: statistical associations with dietary selenium intakes. Bioinorg Chem. 1977;7(1):23–31. doi: 10.1016/s0006-3061(00)80126-x. [DOI] [PubMed] [Google Scholar]
  14. Shamberger R. J., Frost D. V. Possible protective effect of selenium against human cancer. Can Med Assoc J. 1969 Apr 12;100(14):682–682. [PMC free article] [PubMed] [Google Scholar]
  15. Shamberger R. J., Rukovena E., Longfield A. K., Tytko S. A., Deodhar S., Willis C. E. Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J Natl Cancer Inst. 1973 Apr;50(4):863–870. doi: 10.1093/jnci/50.4.863. [DOI] [PubMed] [Google Scholar]
  16. Shamberger R. J., Tytko S. A., Willis C. E. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health. 1976 Sep-Oct;31(5):231–235. doi: 10.1080/00039896.1976.10667225. [DOI] [PubMed] [Google Scholar]
  17. Sundström H., Yrjänheikki E., Kauppila A. Serum selenium in patients with ovarian cancer during and after therapy. Carcinogenesis. 1984 Jun;5(6):731–734. doi: 10.1093/carcin/5.6.731. [DOI] [PubMed] [Google Scholar]
  18. Virtamo J., Valkeila E., Alfthan G., Punsar S., Huttunen J. K., Karvonen M. J. Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer. 1987 Jul 15;60(2):145–148. doi: 10.1002/1097-0142(19870715)60:2<145::aid-cncr2820600203>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  19. Wald N., Boreham J., Bailey A. Serum retinol and subsequent risk of cancer. Br J Cancer. 1986 Dec;54(6):957–961. doi: 10.1038/bjc.1986.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Willett W. C., Polk B. F., Morris J. S., Stampfer M. J., Pressel S., Rosner B., Taylor J. O., Schneider K., Hames C. G. Prediagnostic serum selenium and risk of cancer. Lancet. 1983 Jul 16;2(8342):130–134. doi: 10.1016/s0140-6736(83)90116-2. [DOI] [PubMed] [Google Scholar]
  21. van Noord P. A., Collette H. J., Maas M. J., de Waard F. Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol. 1987 Jun;16(2):318–322. doi: 10.1093/ije/16.2.318. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES